ArticleTrials2016

Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial.

Wenying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.